EMA Withdrawn: Thymanax (agomelatine) — Servier (Ireland) Industries Ltd

View source ↗

Summary

EMA withdrawal of Thymanax (agomelatine) by Servier, status withdrawn as of 31 July 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder Major

Drugs mentioned

• Thymanax (agomelatine)

Snippet

Status: Withdrawn. Therapeutic area: Depressive Disorder, Major. MAH: Servier (Ireland) Industries Ltd. Decision date: 31/07/2022